Skip to main
CLPT

CLPT Stock Forecast & Price Target

CLPT Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ClearPoint Neuro Inc. exhibits a strong potential for sustainable growth, having closed 2023 with a 17% increase in topline revenue and a significant reduction in cash burn. The company is projected to achieve at least 20% revenue growth in 2024, driven by an expanding partnership base and enhanced service offerings. Additionally, with key product approvals and record system installations already adding momentum in 2024, the overall outlook for ClearPoint Neuro remains compelling.

Bears say

ClearPoint Neuro Inc has demonstrated a significant reduction in cash burn throughout 2023, decreasing from $5.8 million in the first quarter to $1.2 million in the fourth quarter, indicating improved cash management. Despite this positive trend, the overall financial landscape could remain challenging for the company, as sustained high levels of cash burn could limit operational flexibility and hinder growth initiatives. Moreover, the reliance on continued cash burn reduction may suggest underlying issues related to revenue generation and market demand for their medical devices, potentially affecting investor confidence.

CLPT has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Clearpoint Neuro Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Clearpoint Neuro Inc (CLPT) Forecast

Analysts have given CLPT a Strong Buy based on their latest research and market trends.

According to 2 analysts, CLPT has a Strong Buy consensus rating as of Jan 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Clearpoint Neuro Inc (CLPT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.